CASIA OpenIR

浏览/检索结果: 共4条,第1-4条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Magnetic-optical dual-modality imaging monitoring chemotherapy efficacy of pancreatic ductal adenocarcinoma with a low-dose fibronectin-targeting Gd-based contrast agent 期刊论文
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 页码: 15
作者:  Zhang, Wenjia;  Liang, Xiaolong;  Zhang, Xinyu;  Tong, Wei;  Shi, Guangyuan;  Guo, Haozhuo;  Jin, Zhengyu;  Tian, Jie;  Du, Yang;  Xue, Huadan
收藏  |  浏览/下载:8/0  |  提交时间:2024/07/03
Molecular imaging  Magnetic resonance imaging  Fluorescence molecular imaging  Pancreatic cancer  Fibronectin  
Optical magnetic multimodality imaging of plectin-1-targeted imaging agent for the precise detection of orthotopic pancreatic ductal adenocarcinoma in mice 期刊论文
EBIOMEDICINE, 2022, 卷号: 80, 页码: 16
作者:  Zhang, Wenjia;  Liang, Xiaolong;  Zhu, Liang;  Zhang, Xinyu;  Jin, Zhengyu;  De, Yang;  Tian, Jie;  Xue, Huadan
收藏  |  浏览/下载:260/0  |  提交时间:2022/09/19
Pancreatic ductal adenocarcinoma (PDAC)  Magnetic particle imaging (MPI)  Superparamagnetic iron oxide nanoparticles (SPIONs)  Fluorescence molecular imaging (FMI)  Magnetic resonance imaging (MRI)  
Multi-Focus Network to Decode Imaging Phenotype for Overall Survival Prediction of Gastric Cancer Patients 期刊论文
IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2021, 卷号: 25, 期号: 10, 页码: 3933-3942
作者:  Zhang, Liwen;  Dong, Di;  Zhong, Lianzhen;  Li, Cong;  Hu, Chaoen;  Yang, Xin;  Liu, Zaiyi;  Wang, Rongpin;  Zhou, Junlin;  Tian, Jie
收藏  |  浏览/下载:287/0  |  提交时间:2021/12/28
Hazards  Feature extraction  Computed tomography  Cancer  Radiomics  Indexes  Bioinformatics  Overall survival  gastric cancer  multi-level  CT image  deep learning  
Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy 期刊论文
CANCER MEDICINE, 2021, 页码: 11
作者:  Su, Qiang;  Liu, Zhenyu;  Chen, Chi;  Gao, Han;  Zhu, Yongbei;  Wang, Liusu;  Pan, Meiqing;  Liu, Jiangang;  Yang, Xin;  Tian, Jie
收藏  |  浏览/下载:274/0  |  提交时间:2021/11/03
biochemical recurrence-free survival  gene signature  LASSO-Cox regression  primary prostate cancer  radical therapy